These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27172809)

  • 1. A matched case-control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication.
    Conrad A; Le Maréchal M; Dupont D; Ducastelle-Leprêtre S; Balsat M; Labussière-Wallet H; Barraco F; Nicolini FE; Thomas X; Gilis L; Chidiac C; Ferry T; Wallet F; Rabodonirina M; Salles G; Michallet M; Ader F;
    Clin Microbiol Infect; 2016 Jul; 22(7):636-41. PubMed ID: 27172809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation.
    Meers S; Lagrou K; Theunissen K; Dierickx D; Delforge M; Devos T; Janssens A; Meersseman W; Verhoef G; Van Eldere J; Maertens J
    Clin Infect Dis; 2010 Apr; 50(8):1127-34. PubMed ID: 20218875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral toxoplasmosis - a late complication of allogeneic haematopoietic stem cell transplantation.
    Zver S; Cernelc P; Mlakar U; Pretnar J
    Bone Marrow Transplant; 1999 Dec; 24(12):1363-5. PubMed ID: 10627650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasmosis after allogeneic haematopoietic cell transplantation: experience using a PCR-guided pre-emptive approach.
    Aerts R; Mercier T; Beckers M; Schoemans H; Lagrou K; Maertens J
    Clin Microbiol Infect; 2022 Mar; 28(3):440-445. PubMed ID: 34634458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasmosis after allogeneic stem cell transplantation--a single centre experience.
    Busemann C; Ribback S; Zimmermann K; Sailer V; Kiefer T; Schmidt CA; Schulz K; Steinmetz I; Dombrowski F; Dölken G; Krüger WH
    Ann Hematol; 2012 Jul; 91(7):1081-9. PubMed ID: 22249208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive pneumococcal disease following adult allogeneic hematopoietic stem cell transplantation.
    Torda A; Chong Q; Lee A; Chen S; Dodds A; Greenwood M; Larsen S; Gilroy N
    Transpl Infect Dis; 2014 Oct; 16(5):751-9. PubMed ID: 25040633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated toxoplasmosis after allogeneic stem cell transplantation in a seronegative recipient.
    Osthoff M; Chew E; Bajel A; Kelsey G; Panek-Hudson Y; Mason K; Szer J; Ritchie D; Slavin M
    Transpl Infect Dis; 2013 Feb; 15(1):E14-9. PubMed ID: 23279790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of cerebral toxoplasmosis in a series of 170 allogeneic hematopoietic stem cell transplant patients.
    Hakko E; Ozkan HA; Karaman K; Gulbas Z
    Transpl Infect Dis; 2013 Dec; 15(6):575-80. PubMed ID: 24103000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasmosis after hematopoietic stem cell transplantation.
    Martino R; Maertens J; Bretagne S; Rovira M; Deconinck E; Ullmann AJ; Held T; Cordonnier C
    Clin Infect Dis; 2000 Nov; 31(5):1188-95. PubMed ID: 11073751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxoplasma prophylaxis in haematopoietic cell transplant recipients: a review of the literature and recommendations.
    Gajurel K; Dhakal R; Montoya JG
    Curr Opin Infect Dis; 2015 Aug; 28(4):283-92. PubMed ID: 26098500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022.
    Aerts R; Mehra V; Groll AH; Martino R; Lagrou K; Robin C; Perruccio K; Blijlevens N; Nucci M; Slavin M; Bretagne S; Cordonnier C;
    Lancet Infect Dis; 2024 May; 24(5):e291-e306. PubMed ID: 38134949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and incidence of toxoplasmosis after autologous hematopoietic stem cell transplantation: A retrospective study and literature review.
    Kitahara M; Hiroshima Y; Norose K; Hikosaka K; Kazumoto H; Uematsu N; Shishido T; Kaiume H; Sato K; Ueki T; Sumi M; Watanabe M; Kobayashi H
    Transpl Infect Dis; 2021 Dec; 23(6):e13726. PubMed ID: 34542220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation.
    Lim Z; Baker B; Zuckerman M; Wade JJ; Ceesay M; Ho AY; Devereux S; Mufti GJ; Pagliuca A
    J Infect; 2007 Feb; 54(2):e83-6. PubMed ID: 16806484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
    Finke J; Bethge WA; Schmoor C; Ottinger HD; Stelljes M; Zander AR; Volin L; Ruutu T; Heim DA; Schwerdtfeger R; Kolbe K; Mayer J; Maertens JA; Linkesch W; Holler E; Koza V; Bornhäuser M; Einsele H; Kolb HJ; Bertz H; Egger M; Grishina O; Socié G;
    Lancet Oncol; 2009 Sep; 10(9):855-64. PubMed ID: 19695955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Toxoplasma gondii infection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny.
    Cavattoni I; Ayuk F; Zander AR; Zabelina T; Bacher A; Cayroglu E; Knospe V; Illies T; Aepfelbacher M; Richard G; Kröger N; Bacher U
    Leuk Lymphoma; 2010 Aug; 51(8):1530-5. PubMed ID: 20578813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation.
    Martino R; Bretagne S; Einsele H; Maertens J; Ullmann AJ; Parody R; Schumacher U; Pautas C; Theunissen K; Schindel C; Muñoz C; Margall N; Cordonnier C;
    Clin Infect Dis; 2005 Jan; 40(1):67-78. PubMed ID: 15614694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low seroprevalence and low incidence of infection with Toxoplasma gondii (Nicolle et Manceaux, 1908) in pediatric hematopoietic cell transplantation donors and recipients: Polish nationwide study.
    Czyzewski K; Fraczkiewicz J; Salamonowicz M; Pieczonka A; Zajac-Spychala O; Zaucha-Prazmo A; Gozdzik J; Styczynski J
    Folia Parasitol (Praha); 2019 Nov; 66():. PubMed ID: 31823860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxoplasma gondii serology and stem cell transplantation in Chinese.
    Au WY; Cheng VC; Lie AK
    Transplant Proc; 2005 Dec; 37(10):4497-9. PubMed ID: 16387153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem-cell transplant recipients.
    Bretagne S; Costa JM; Foulet F; Jabot-Lestang L; Baud-Camus F; Cordonnier C
    Transpl Infect Dis; 2000 Sep; 2(3):127-32. PubMed ID: 11429023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience.
    Slavin MA; Meyers JD; Remington JS; Hackman RC
    Bone Marrow Transplant; 1994 May; 13(5):549-57. PubMed ID: 8054907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.